Back to Journals » Drug Design, Development and Therapy » Volume 11

Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: a meta-analysis of randomized controlled trials

Total article views   Abstract views HTML views PDF downloads Totals
6,631 Dovepress* 4,793 482+ 579 5,275
PubMed Central* 0 1,356 294 1,356
Totals 4,793 1,838 873 6,631
*Since 13 October 2017
+Since July 2016

View citations on PubMed Central and Google Scholar